Stock A078140 DAEBONGLS.CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Daebongls.Co.,Ltd.

Equities

A078140

KR7078140001

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-06-12 pm EDT 		5-day change 1st Jan Change
10,600 KRW +2.42% Intraday chart for Daebongls.Co.,Ltd. +4.43% +15.72%
May. 16 Daebongls.Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 20 Daebongls.Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Daebongls. Co., Ltd. is a Korea-based company engaged in the manufacture of raw materials for pharmaceuticals and cosmetics. The Company operates its business through two main divisions: cosmetic division, which provides aloe vera gels, beta carotens, calamines, diaformers, emulgades and others for conditioners, emulsifiers, emollients, polymers, thickeners and others; pharmaceutical division, which provides almagates, bentonites, calcitriols, erdosteines, fish oil and others for antibiotics, cough products, expectorants and others. In addition, it is involved in the provision of food chemical additives, fish feedstuff and others. The Company distributes its products within domestic market and to overseas markets, including Japan, America and other Southeast Asian countries.

Number of employees: 125

Sales per Business

KRW in Million2022Weight2023Weight Delta
Manufacturing
82.7 %
75,234 80.5 % 72,505 82.7 % -3.63%
Research
16.9 %
17,938 19.2 % 14,843 16.9 % -17.26%
Wholesale
0.3 %
332 0.4 % 293 0.3 % -11.59%
Adjustment
0.0 %
- - -19 0.0 % -

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
98.2 %
92,165 98.6 % 86,036 98.2 % -6.65%
International
1.8 %
1,339 1.4 % 1,586 1.8 % +18.41%

Managers

Managers TitleAgeSince
Jong-Ho Park FOU
 Founder 79 86-07-07
Jin-Oh Park CEO
 Chief Executive Officer 52 01-04-30
Jae-Yeon Im BRD
 Director/Board Member 56 -
Wang-Bae Kim PRN
 Corporate Officer/Principal 61 18-02-28
Jun-Seng Lee AUD
 Comptroller/Controller/Auditor 63 03-02-28
Chang-Woo Son PRN
 Corporate Officer/Principal 56 03-12-31

Members of the board

Members of the board TitleAgeSince
Jin-Oh Park CEO
 Chief Executive Officer 52 01-04-30
Chang-Woo Son PRN
 Corporate Officer/Principal 56 03-12-31
Jong-Ho Park FOU
 Founder 79 86-07-07
Tae-Won Park BRD
 Director/Board Member 53 19-03-28
Wang-Bae Kim PRN
 Corporate Officer/Principal 61 18-02-28
Jae-Yeon Im BRD
 Director/Board Member 56 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 11,086,579 5,302,989 ( 47.83 %) 138,410 ( 1.248 %) 47.83 %

Shareholders

NameEquities%Valuation
Jin-Oh Park
22.60 %
2,505,600 22.60 % 20 M ₩
Jong-Ho Park
19.55 %
2,167,900 19.55 % 17 M ₩
Ji-won Lee
2.724 %
302,000 2.724 % 2 M ₩
Se-in Park
2.616 %
290,000 2.616 % 2 M ₩
Se-hyeon Park
1.984 %
220,000 1.984 % 2 M ₩
DAEBONGLS.CO.,LTD.
1.248 %
138,410 1.248 % 1 M ₩
Sung-bin Sa
1.034 %
114,600 1.034 % 912 131 ₩
Young-ja Sa
0.3788 %
42,000 0.3788 % 334 289 ₩
DFA Australia Ltd.
0.001398 %
155 0.001398 % 1 234 ₩

Holdings

NameEquities%Valuation
P&K SKIN RESEARCH CENTER CO., LTD.
55.91%
 16,779,844 55.91% 36,297,487 $
DAEBONGLS.CO.,LTD.
1.25%
 138,410 1.25% 1,101,641 $

Company contact information

DaebongLS Co., Ltd.

123 Neungheodae-ro 649 beon-gil Namdong-gu

21697, Inchon

+

http://www.daebongls.co.kr
address Daebongls.Co.,Ltd.(A078140)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
DAEBONGLS.CO.,LTD. Stock Daebongls.Co.,Ltd.
+15.72% 84.04M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+50.25% 781B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.04% 350B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.54% 330B
ABBVIE INC. Stock AbbVie Inc.
+7.56% 293B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.91% 248B
ROCHE HOLDING AG Stock Roche Holding AG
+0.53% 221B
NOVARTIS AG Stock Novartis AG
+11.06% 217B
AMGEN INC. Stock Amgen Inc.
+3.55% 162B
PFIZER, INC. Stock Pfizer, Inc.
-3.91% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A078140 Stock
  4. Company Daebongls.Co.,Ltd.